受体酪氨酸激酶在血管生成中的作用 - Suppr

Suppr

超能文献

[Role of receptor tyrosine kinase in the angiogenesis].

作者信息

Meyer S, Hafner C, Vogt T

机构信息

Klinik und Poliklinik für Dermatologie, Universität Regensburg, Germany.

出版信息

Hautarzt. 2002 Sep;53(9):629-42. doi: 10.1007/s00105-002-0425-x.

DOI:10.1007/s00105-002-0425-x

PMID:12432901

Abstract

摘要

相似文献

[Role of receptor tyrosine kinase in the angiogenesis].

Hautarzt. 2002 Sep;53(9):629-42. doi: 10.1007/s00105-002-0425-x.

Complementary and coordinated roles of the VEGFs and angiopoietins during normal and pathologic vascular formation.

Cold Spring Harb Symp Quant Biol. 2002;67:267-73. doi: 10.1101/sqb.2002.67.267.

Selective functions of angiopoietins and vascular endothelial growth factor on blood vessels: the concept of "vascular domain".

Cold Spring Harb Symp Quant Biol. 2002;67:171-80. doi: 10.1101/sqb.2002.67.171.

VEGFs, angiopoietins, Ephrins and their receptors: putative targets for tumor therapy?

Ann Hematol. 2002;81 Suppl 2:S66.

Regulation of angiogenesis via vascular endothelial growth factor receptors.

Cancer Res. 2000 Jan 15;60(2):203-12.

Hepatocyte growth factor/scatter factor can induce angiogenesis independently of vascular endothelial growth factor.

Arterioscler Thromb Vasc Biol. 2003 Jan 1;23(1):69-75. doi: 10.1161/01.atv.0000048701.86621.d0.

Tumor-derived vascular endothelial growth factor up-regulates angiopoietin-2 in host endothelium and destabilizes host vasculature, supporting angiogenesis in ovarian cancer.

Cancer Res. 2003 Jun 15;63(12):3403-12.

The pivotal role of VEGF in tumor angiogenesis: molecular facts and therapeutic opportunities.

Cancer Metastasis Rev. 1998 Jun;17(2):241-8. doi: 10.1023/a:1006027124696.

[The biology of lymphatic vessels - new findings ].

Duodecim. 1998;114(4):343-8.

Angiopoietin-1 and pulmonary hypertension: cause or cure?

Circ Res. 2003 May 16;92(9):947-9. doi: 10.1161/01.RES.0000074031.94558.99.

引用本文的文献

Eph receptors and ephrin ligands: important players in angiogenesis and tumor angiogenesis.

J Oncol. 2010;2010:135285. doi: 10.1155/2010/135285. Epub 2010 Mar 10.

本文引用的文献

Clinical experience with angiogenesis signaling inhibitors: focus on vascular endothelial growth factor (VEGF) blockers.

Cancer Control. 2002 Mar-Apr;9(2 Suppl):36-44. doi: 10.1177/107327480200902S05.

The antiangiogenic agent neovastat (AE-941) inhibits vascular endothelial growth factor-mediated biological effects.

Clin Cancer Res. 2002 Apr;8(4):1242-50.

Mechanisms of normal and tumor-derived angiogenesis.

Am J Physiol Cell Physiol. 2002 May;282(5):C947-70. doi: 10.1152/ajpcell.00389.2001.

Importance of vascular phenotype by basic fibroblast growth factor, and influence of the angiogenic factors basic fibroblast growth factor/fibroblast growth factor receptor-1 and ephrin-A1/EphA2 on melanoma progression.

Am J Pathol. 2002 Mar;160(3):1009-19. doi: 10.1016/S0002-9440(10)64922-X.

The ephrins and Eph receptors in angiogenesis.

Cytokine Growth Factor Rev. 2002 Feb;13(1):75-85. doi: 10.1016/s1359-6101(01)00031-4.

[Tumor angiogenesis: new approaches to cancer therapy].

Onkologie. 2001 Feb;24 Suppl 1:1-5. doi: 10.1159/000055156.

Oncogenic kinase signalling.

Nature. 2001 May 17;411(6835):355-65. doi: 10.1038/35077225.

Molecular regulation of tumor cell vasculogenic mimicry by tyrosine phosphorylation: role of epithelial cell kinase (Eck/EphA2).

Cancer Res. 2001 Apr 15;61(8):3250-5.

Selective inhibition of vascular endothelial growth factor (VEGF) receptor 2 (KDR/Flk-1) activity by a monoclonal anti-VEGF antibody blocks tumor growth in mice.

Cancer Res. 2000 Sep 15;60(18):5117-24.

SU6668 is a potent antiangiogenic and antitumor agent that induces regression of established tumors.

Cancer Res. 2000 Aug 1;60(15):4152-60.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验